Latest Breaking News On - International myeloma working group - Page 4 : comparemela.com

Exciting results show anito-cel CAR-T is safe, durable for high-risk multiple myeloma

Exciting results show anito-cel CAR-T is safe, durable for high-risk multiple myeloma
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesBydrew amorosiMatthewj frigaultMindy valcarcelHarvard medical schoolInternational myeloma working groupCancer centerMass general cancer centerCell therapy next peer perspective board

Daratumumab-based regimen a future standard for certain patients with multiple myeloma

Daratumumab-based regimen a future standard for certain patients with multiple myeloma
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesPieter sonneveldMansir shahInternational myeloma working groupJanssen pharmaceuticalsErasmus mc cancer instituteErasmus university of rotterdamRutgers cancer institute of new jerseyRwjbarnabas healthEuropean myeloma networkBristol myers squibbThenew england journalErasmus universityCancer institute

C4 Therapeutics, Inc Announces Positive Data from CFT7455 Phase 1 Trial in Relapsed/Refractory Multiple Myeloma

C4 Therapeutics, Inc. presented clinical data from the ongoing Phase 1 dose escalation portion of its Phase 1/2 clinical trial of CFT7455, a MonoDAC?? degrader of IKZF1/3, for the potential treatment.

International myeloma working groupTherapeutics incStable diseasePartial responseStringent complete responseVery good partial responseComplete phase

New Analyses Demonstrate Versatility and Continued Efficacy of TALVEY™ in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

/PRNewswire/ Johnson & Johnson announced today an analysis from the Phase 1/2 MonumenTAL-1 study of TALVEY™ (talquetamab-tgvs) in patients with relapsed or.

United statesSan franciscoChristie corbettSatu glaweChristoph heuckAmerican society of hematologyNone of janssen research developmentHematology clinical developmentEuropean commissionJanssen research developmentEastern cooperative oncology groupJanssen biotech incUniversity of californiaMyeloma programInternational myeloma working groupExchange commission

CARsgen Presents Updated Research Results on Zevor-cel at 2023 ASH Annual Meeting

CARsgen Presents Updated Research Results on Zevor-cel at 2023 ASH Annual Meeting
kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.

United statesZevorcabtagene autoleucelEuropean medicines agencyInternational staging systemAmerican society of hematologyCarsgen therapeutics holdingsInternational myeloma working groupPrnewswire carsgen therapeutics holdings limited stock codeTherapeutics holdings limitedStock codeAnnual meetingThree year follow upSafety resultsChinese patientsRefractory multipleNew drug application